351 related articles for article (PubMed ID: 32232775)
1. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Reduced in Euthyroid Children with Newly Diagnosed Hashimoto's Thyroiditis: A Pilot Study.
Aversa T; Ruggeri RM; Corica D; Cristani MT; Pepe G; Vicchio TM; Alibrandi A; Trimarchi F; Cannavò S; Pajno GB; Wasniewska MG
Horm Res Paediatr; 2021; 94(3-4):144-150. PubMed ID: 34237741
[TBL] [Abstract][Full Text] [Related]
3. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.
Ruggeri RM; Cristani M; Vicchio TM; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
J Endocrinol Invest; 2019 Feb; 42(2):199-205. PubMed ID: 29796799
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Csiha S; Molnár I; Halmi S; Hutkai D; Lőrincz H; Somodi S; Katkó M; Harangi M; Paragh G; Nagy EV; Berta E; Bodor M
Front Endocrinol (Lausanne); 2023; 14():1187725. PubMed ID: 37305044
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis.
Ruggeri RM; Vicchio TM; Cristani M; Certo R; Caccamo D; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
Thyroid; 2016 Apr; 26(4):504-11. PubMed ID: 26854840
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
7. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
[TBL] [Abstract][Full Text] [Related]
8. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
[No Abstract] [Full Text] [Related]
10. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
11. The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts.
Mitran CI; Nicolae I; Tampa M; Mitran MI; Caruntu C; Sarbu MI; Ene CD; Matei C; Ionescu AC; Georgescu SR; Popa MI
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635193
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
13. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
[TBL] [Abstract][Full Text] [Related]
14. Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis.
Ruggeri RM; Giovinazzo S; Barbalace MC; Cristani M; Alibrandi A; Vicchio TM; Giuffrida G; Aguennouz MH; Malaguti M; Angeloni C; Trimarchi F; Hrelia S; Campennì A; Cannavò S
Thyroid; 2021 Jan; 31(1):96-105. PubMed ID: 32729374
[No Abstract] [Full Text] [Related]
15. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
16. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of paraoxonase activity and association with serum advanced glycation end products as reliable markers of oxidative stress in Hashimoto's thyroiditis.
Ruggeri RM; Cristani MT; Crupi F; Molonia MS; Burduja N; Alibrandi A; Campennì A; Cannavò S
Minerva Endocrinol (Torino); 2022 Oct; ():. PubMed ID: 36251022
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
19. Soluble receptor for advanced glycation end products as a vasculopathy biomarker in sickle cell disease.
Safwat NA; Kenny MA
Pediatr Res; 2018 Dec; 84(6):869-874. PubMed ID: 30367158
[TBL] [Abstract][Full Text] [Related]
20. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
Emami N; Alizadeh A; Maleki-Hajiagha A; Dizavi A; Vesali S; Moini A
J Ovarian Res; 2023 Jun; 16(1):127. PubMed ID: 37391740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
